Cabaletta Bio
CABA
54 hedge funds and large institutions have $7.76M invested in Cabaletta Bio in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.
1,025% more call options, than puts
Call options by funds: $135K | Put options by funds: $12K
2% less funds holding
Funds holding: 55 → 54 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
21.49% less ownership
Funds ownership: 68.12% → 46.63% (-21%)
56% less capital invested
Capital invested by funds: $17.8M → $7.76M (-$10.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EP
Eversept Partners
New York
|
+$675K |
| 2 |
Renaissance Technologies
New York
|
+$424K |
| 3 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
+$399K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$305K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$273K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
-$2.19M |
| 2 |
SC
Samlyn Capital
New York
|
-$2.04M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.51M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$934K |
| 5 |
DAM
DLD Asset Management
New York
|
-$261K |
CABA Hedge Fund Activity: Q3 2022 in Review
54 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q3 2022, worth a combined $7.76M — down 56% from $17.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CABA and 9 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 11 added.
The largest buyer was Eversept Partners, opening a new position worth an estimated $675K. The largest seller was 5AM Venture Management, exiting entirely with an estimated $2.19M sold.
- 54 institutional investors held Cabaletta Bio (CABA) as of Q3 2022, down from 55 in Q2 2022.
- Funds reported $7.76M of Cabaletta Bio stock for Q3 2022, down 56% quarter-over-quarter.
- 9 funds opened new Cabaletta Bio positions in Q3 2022 and 10 closed out, a net change of -1 holder.
- The largest Cabaletta Bio buyer in Q3 2022 was Eversept Partners, an estimated $675K added.
- The largest Cabaletta Bio seller in Q3 2022 was 5AM Venture Management, an estimated $2.19M sold.
Based on aggregated 13F filings for Q3 2022.